Victoza (Liraglutide)

Victoza is given to adults and children over 10 years old with type 2 diabetes as it lowers blood sugar and A1C levels.  Victoza is lowers risk of stroke, heart attack and death.  

Prescription Victoza supports your pancreas to produce more insulin by assisting beta cells work properly.  This helps control your blood sugar as you make and release your own insulin.

Victoza works in many ways.  Victoza slows food from leaving your stomach, thus slowing down the process which helps blood sugar control.  Victoza prevents the liver from producing excess sugar.  Victoza supports the pancreas to make more insulin when blood sugar is too high.

Victoza may also cause weight loss.  Although Victoza is not insulin, it can be taken with insulin as directed by your physician.  Always inject insulin as a separate injection at some distance from the Victoza injection.  You can however inject Victoza at the same time as long acting insulin. 

Victoza may be prescribed along with other diabetes medicines including metformin and certain other medicines.

The standard dose of Victoza is either 1.2mg or 1.8mg as a once daily injection and should be used alongside of good diet and exercise in patients with type 2 diabetes to reduce the risk of cardiovascular events.  Victoza is not used in type 1 diabetes.

In 2019, when comparing Victoza pen price to USA Victoza coupon price, InsulinHub was found to offer a discount of approximately 50% in Victoza savings.

Buy Victoza pens from InsulinHub.com for the best Victoza price.

Information about Victoza (Liraglutide)

Victoza is a prescription medication that contains Liraglutide as its active ingredient. It is primarily used to manage type 2 diabetes and to aid in weight loss. Liraglutide mimics the action of a natural hormone called GLP-1 (glucagon-like peptide-1), which helps regulate blood sugar levels, control appetite, and slow down gastric emptying. Victoza is typically administered as a subcutaneous injection.

Product Highlights

• To improve blood sugar control in adults with type 2 diabetes, in conjunction with diet and exercise.
• As an adjunct to a reduced-calorie diet and increased physical activity for weight loss in individuals with obesity or overweight with associated health conditions (such as high blood pressure, type 2 diabetes, or high cholesterol).

Key Ingredient

• Liraglutide

Key Benefits

• Helps lower blood sugar levels by stimulating insulin release in response to meals and inhibiting excessive glucagon production.
• Liraglutide has been shown to help with weight reduction by promoting satiety and reducing appetite.
• Victoza has been shown to reduce the risk of heart attack, stroke, and cardiovascular death in people with type 2 diabetes who also have cardiovascular disease.
• Administered as a once-daily injection, making it easier to manage compared to multiple daily injections for insulin therapy.
• Can be used alongside other diabetes medications and is an alternative to insulin.

Direction of Use

• Victoza is injected subcutaneously (under the skin) once daily, at any time of the day, with or without food.
• Typically, the starting dose is 0.6 mg once daily for the first week. After that, the dose is usually increased to 1.2 mg, and can be increased further to 1.8 mg depending on the patient's tolerance and response.
• Typical injection sites include the thigh, abdomen, or upper arm. Rotate injection sites to avoid irritation.
• If you miss a dose, take it as soon as you recall, unless it's almost time for your next dose. Do not take two doses at once.

Safety Concerns

• Liraglutide has been associated with an increased risk of pancreatitis (inflammation of the pancreas). Symptoms can include intense abdominal pain, nausea, and vomiting. Seek immediate medical attention if these occur. 
• Victoza may cause dehydration, which can affect kidney function. Caution is advised in individuals with existing kidney issues.
• There is a risk of thyroid C-cell tumors in animal studies. It is not recommended for people with a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
• Frequent side effects may include nausea, vomiting, diarrhea, and constipation. These symptoms often improve over time.
• When used in combination with other diabetes medications like sulfonylureas or insulin, Victoza can increase the risk of low blood sugar (hypoglycemia).
• Victoza may cause a mild increase in heart rate, which should be monitored, especially in people with heart conditions.

Avoid Victoza (Liraglutide) If

• You have a history of pancreatitis or other pancreas-related issues.
• You have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). 
• You are pregnant or planning to become pregnant. Victoza is not recommended during pregnancy, as it could harm the fetus. You should switch to an alternative treatment if pregnancy is planned.
• You are breastfeeding. It is not known whether Victoza passes into breast milk, so you should consult your doctor about alternative options.
• You have severe kidney disease or have severe gastrointestinal disorders that may affect absorption or affect how your body handles the medication.
• You have a history of severe allergic reactions to liraglutide or any of the ingredients in the medication.

This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.